Analyst Initiates Coverage of Metabolix with Analyst Brief by Small Cap Street and BrokerBank Securities, Inc.

NEW YORK, Sept. 22, 2014 /PRNewswire/ -- Metabolix, Inc. (MBLX: NASDAQ) is an innovation-driven bioscience company focused on delivering sustainable solutions to the plastics and chemicals industries. They have core capabilities in microbial genetics, fermentation process engineering, chemical engineering, polymer science, plant genetics and botanical science, and have also assembled these capabilities in a way that has allowed them to integrate their biotechnology research with real world chemical engineering and industrial practice.

A brief analyst report detailing recent trading activity and analyst opinion is available by using the following link:

http://bit.ly/-MBLX-AnalystReport

Copy and paste to browser may be required.

About Small Cap Street

Once you read our reports written by our team of financial analysts you will understand that we make every effort to provide informative equity research reports for interested parties at no cost.

Our Financial Analysts spend countless hours researching stocks. They include stocks traded in the NYSE, NASDAQ, and OTCBB exchanges. These reports include a straightforward assessment of the company by a financial analyst who has pledged to remain free of influence when writing research reports.

Forward-Looking Disclaimer    

This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward- looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.   

Compliance Procedure   

Content is researched, written and reviewed on a best-effort basis. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. We do not engage in high frequency trading.

A full disclaimer can be found by viewing the full analyst report.

If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at [email protected]. For any urgent concerns or inquiries please contact us at [email protected].   

BrokerBank Securities, Inc. is a member of the Financial Industry Regulatory Authority, CRD number #130116.

SOURCE Small Cap Street